학술논문

Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies
Document Type
Article
Source
In: British Journal of Dermatology. (British Journal of Dermatology, April 2024, 190(4):559-564)
Subject
Language
English
ISSN
13652133
00070963